Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.

[1]  F. Montorsi,et al.  Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. , 2014, European urology.

[2]  L. Salomon,et al.  [Postoperative radiotherapy of prostate cancer]. , 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[3]  T. Wiegel,et al.  Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis. , 2013, European urology.

[4]  L. Lacombe,et al.  The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients. , 2013, European urology.

[5]  A. Vickers,et al.  Re: Alberto Briganti, Thomas Wiegel, Steven Joniau, et al. early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 2012;62:472-87: statistical concerns , 2013, European urology.

[6]  L. Collette,et al.  Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) , 2012, The Lancet.

[7]  T. Wiegel,et al.  Radiotherapy after radical prostatectomy: immediate or early delayed? , 2012, Strahlentherapie und Onkologie.

[8]  F. Montorsi,et al.  Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. , 2012, European urology.

[9]  C. King.  The timing of salvage radiotherapy after radical prostatectomy: a systematic review. , 2012, International journal of radiation oncology, biology, physics.

[10]  T. Wiegel,et al.  Salvage radiotherapy after prostatectomy - what is the best time to treat? , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  A. Dicker,et al.  Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling. , 2012, European journal of cancer.

[12]  M. Kattan,et al.  Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. , 2012, The Journal of urology.

[13]  A. Zietman,et al.  Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. , 2012, European urology.

[14]  P. Scardino,et al.  Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy. , 2011, European urology.

[15]  N. Lumen,et al.  High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results. , 2011, European urology.

[16]  W. De Gersem,et al.  A comparison of the acute toxicity profile between two-dimensional and three-dimensional image-guided radiotherapy for postoperative prostate cancer. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

[17]  R. Thompson,et al.  Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. , 2011, European urology.

[18]  M. Moussa,et al.  The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer , 2011, Prostate Cancer and Prostatic Diseases.

[19]  Misop Han,et al.  Predicting 15-year prostate cancer specific mortality after radical prostatectomy. , 2011, The Journal of urology.

[20]  P. Mongiat-artus,et al.  [Postoperative radiotherapy of prostate cancer]. , 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[21]  N. Willich,et al.  Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  E. Messing,et al.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. , 2009, The Journal of urology.

[23]  E. Klein,et al.  The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival. , 2008, The Journal of urology.

[24]  C. King,et al.  Radiotherapy after prostatectomy: is the evidence for dose escalation out there? , 2008, International journal of radiation oncology, biology, physics.

[25]  M. Kattan,et al.  Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. , 2005, The Journal of urology.

[26]  I. Thompson,et al.  Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Parmar,et al.  RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery). , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[28]  E. Messing,et al.  Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. , 2006, JAMA.

[29]  A W Partin,et al.  Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.

[30]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[31]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .